ImmuCell
ICCC
26 hedge funds and large institutions have $7.87M invested in ImmuCell in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0.04% less ownership
Funds ownership: 14.19% → 14.15% (-0.04%)
3% less capital invested
Capital invested by funds: $8.08M → $7.87M (-$205K)
4% less funds holding
Funds holding: 27 → 26 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
Steadtrust
Allen,
Texas
|
+$148K |
| 2 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$143K |
| 3 |
Morgan Stanley
New York
|
+$115K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$106K |
| 5 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$280K |
| 2 |
SRC
Shufro Rose & Co
New York
|
-$153K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$47.3K |
| 4 |
Renaissance Technologies
New York
|
-$38.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $4 | – | – | – |
|
27
Citigroup
New York
| – | -$1.1K | -170 | Closed |
|
28
Barclays
London,
United Kingdom
| – | -$44 | -7 | Closed |
|
ICCC Hedge Fund Activity: Q4 2025 in Review
26 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2025, worth a combined $7.87M — down 2.5% from $8.08M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ICCC and 2 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 9 added.
The largest buyer was Steadtrust, adding an estimated $148K. The largest seller was Dauntless Investment Group, cutting an estimated $280K.
- 26 institutional investors held ImmuCell (ICCC) as of Q4 2025, down from 27 in Q3 2025.
- Funds reported $7.87M of ImmuCell stock for Q4 2025, down 2.5% quarter-over-quarter.
- 2 funds opened new ImmuCell positions in Q4 2025 and 3 closed out, a net change of -1 holder.
- The largest ImmuCell buyer in Q4 2025 was Steadtrust, an estimated $148K added.
- The largest ImmuCell seller in Q4 2025 was Dauntless Investment Group, an estimated $280K sold.
Based on aggregated 13F filings for Q4 2025.